Ruchi Tandon

Summary

Publications

  1. ncbi Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment
    Ruchi Tandon
    Department of Pharmacology, New Drug Discovery Research, Ranbaxy Laboratories Limited, Plot No 20, Sector 18, Gurgaon 122 001, Haryana, India
    Eur J Pharmacol 667:56-65. 2011

Detail Information

Publications1

  1. ncbi Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment
    Ruchi Tandon
    Department of Pharmacology, New Drug Discovery Research, Ranbaxy Laboratories Limited, Plot No 20, Sector 18, Gurgaon 122 001, Haryana, India
    Eur J Pharmacol 667:56-65. 2011
    ....